Tokyo (awp / afp) – The Tokyo Stock Exchange continued to advance Thursday morning, as investors were comforted by the rise in Wall Street indices the day before, on hopes of a lesser impact of the Omicron variant on the economy.
The flagship Nikkei index gained 0.41% to 28,678.84 points around 00:45 GMT and the extended Topix index 0.5% to 1,981.30 points.
The Japanese market is supported by the positive tone of the New York Stock Exchange on Wednesday, but “the Nikkei should move in a narrow range” in a context of waiting before the Christmas truce of markets in Europe and the United States, a Okasan Online Securities commented in a note.
On the side of values
EISAI: the title of the Japanese pharmaceutical group Eisai plummeted 8.84% to 6,492 yen. A committee of the Japanese Ministry of Health ruled on Wednesday that it would need more data to determine the effectiveness of Aduhelm (aducanumab), a treatment supposed to slow the development of Alzheimer’s disease developed by Eisai in partnership with the American Biogen.
The European Medicines Agency issued a negative opinion last week to the application for the European marketing of this treatment, which was also authorized in June in the United States.
On the currency and oil side
The yen retreated against the dollar, at a rate of one dollar against 114.18 yen at around 12.50 a.m. GMT against 114.10 yen on Wednesday at 9 p.m. GMT.
The Japanese currency fell more sharply against the euro, which was worth 129.46 yen against 129.23 yen the day before.
A euro was also traded for 1.1339 dollars, against 1.1326 dollars on Wednesday.
Oil continued to rise: after 00:40 GMT the price of a US barrel of WTI rose 0.23% to 72.93 dollars.
mac / mlb